Kida Yoshihisa, Hasegawa Toshinori, Iwai Yoshiyasu, Shuto Takashi, Satoh Manabu, Kondoh Takeshi, Hayashi Motohiro
Department of Neurosurgery, General Kamiiida Daiichi Hospital, Scientific Committee of Japanese Gamma Knife Society, Japan.
Department of Neurosurgery, Komaki City Hospital, Scientific Committee of Japanese Gamma Knife Society, Japan.
Surg Neurol Int. 2015 May 14;6(Suppl 5):S249-57. doi: 10.4103/2152-7806.157071. eCollection 2015.
A group study for symptomatic cavernous malformation (CM) treated with gamma knife (GK) surgery was performed.
A total of 298 cases collected from 23 GK centers across Japan were included. Hemorrhage was the most common manifestation, followed by seizures and neurological deficits. Most of the lesions were located in the brainstem and basal ganglia, followed by the cerebral or cerebellar hemispheres. The CMs, which had a mean diameter of 14.8 mm, were treated using GK surgery with a mean marginal dose of 14.6 Gy.
In terms of hemorrhage-free survival (HFS), a marked dissociation was confirmed between the hemorrhage and seizure groups, while no obvious difference was noted between sexes. Superficial CMs located in cerebellum or lobar regions responded to the treatment better than deeply located CMs in the basal ganglia or brainstem. No significant difference of dose-dependent response was seen for three different ranges of marginal dose: Less than 15 Gy, between 15 and 20 Gy, and more than 20 Gy. Complications were more frequent after a marginal dose of over 15 Gy and in patients with lesions more than 15 mm in diameter. The rates of annual hemorrhage were estimated to be 7.4% during the first 2 years after radiosurgery and 2.8% thereafter. The overall hemorrhage rate after radiosurgery was 4.4%/year/patient.
The risk of hemorrhage is considerably reduced after GK treatment. The HFS as well as annual hemorrhage rate after GK treatment was apparently superior to that after conservative treatment for symptomatic CMs. To optimize the success of GK treatment, it is important to reduce the incidence of complications.
开展了一项关于伽玛刀(GK)手术治疗症状性海绵状血管畸形(CM)的群体研究。
纳入了从日本23个GK中心收集的总共298例病例。出血是最常见的表现,其次是癫痫发作和神经功能缺损。大多数病变位于脑干和基底神经节,其次是大脑或小脑半球。这些平均直径为14.8毫米的CM采用GK手术治疗,平均边缘剂量为14.6 Gy。
在无出血生存期(HFS)方面,出血组和癫痫发作组之间证实存在明显差异,而性别之间未观察到明显差异。位于小脑或脑叶区域的浅表CM对治疗的反应优于位于基底神经节或脑干的深部CM。对于边缘剂量的三个不同范围(小于15 Gy、15至20 Gy之间以及大于20 Gy),未观察到剂量依赖性反应的显著差异。边缘剂量超过15 Gy以及病变直径超过15毫米的患者并发症更频繁。放射外科手术后前2年的年出血率估计为7.4%,此后为2.8%。放射外科手术后的总体出血率为4.4%/年/患者。
GK治疗后出血风险显著降低。GK治疗后的HFS以及年出血率明显优于症状性CM保守治疗后的情况。为优化GK治疗的成功率,降低并发症发生率很重要。